Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.

@article{Wildemeersch2001TreatmentOM,
  title={Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.},
  author={Dirk A Wildemeersch and Etienne H Schacht},
  journal={The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception},
  year={2001},
  volume={6 2},
  pages={93-101}
}
OBJECTIVE To evaluate the effect on menstrual blood loss of a novel 'frameless' intrauterine drug delivery system, the FibroPlant levonorgestrel intrauterine system (IUS), releasing 14 microg of levonorgestrel/day. An ancillary objective was to evaluate the contraceptive performance. STUDY DESIGN This was an open-label, non-comparative ongoing pilot study. Thirty-two insertions were performed in fertile women aged between 31 and 51 years for the treatment of menorrhagia, as well as for… CONTINUE READING